BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Staging
11 results:

  • 1. A high mutation rate of immunoglobulin heavy chain variable region gene associates with a poor survival and chemotherapy response of mantle cell lymphoma patients.
    Li X; Wu N; Li B
    Medicine (Baltimore); 2019 May; 98(22):e15811. PubMed ID: 31145313
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical significance and expression of PUMA, mcl-1, and p53 in human renal cell carcinoma and para-carcinoma tissues.
    Xia HB; Cui HW; Su L; Zhang ZH; Yang XY; Ning SQ; Su XL
    Genet Mol Res; 2017 Jul; 16(3):. PubMed ID: 28692117
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
    Petković I; Stojnev S; Krstić M; Pejčić I; Vrbić S
    Vojnosanit Pregl; 2016 Nov; 73(11):1072-5. PubMed ID: 29341562
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging.
    Challagundla P; Medeiros LJ; Kanagal-Shamanna R; Miranda RN; Jorgensen JL
    Am J Clin Pathol; 2014 Dec; 142(6):837-44. PubMed ID: 25389338
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. How to manage mantle cell lymphoma.
    Dreyling M; Ferrero S; Hermine O
    Leukemia; 2014 Nov; 28(11):2117-30. PubMed ID: 24854989
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The downregulation of mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
    Peddaboina C; Jupiter D; Fletcher S; Yap JL; Rai A; Tobin RP; Jiang W; Rascoe P; Rogers MK; Smythe WR; Cao X
    BMC Cancer; 2012 Nov; 12():541. PubMed ID: 23171055
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Aberrant expression of CD19 and CD43 in a patient with therapy-related acute myeloid leukemia and a history of mantle cell lymphoma.
    Hsieh YC; Lin CL; Tsao CJ; Hsieh PP; Tzeng CC; Chuang SS
    Kaohsiung J Med Sci; 2009 Jul; 25(7):389-94. PubMed ID: 19605331
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, mcl-1, and Bag-1 proteins.
    Faria JR; Yamamoto M; Faria RM; Kerbauy J; Oliveira JS
    Braz J Med Biol Res; 2006 Mar; 39(3):327-33. PubMed ID: 16501812
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
    Ravandi-Kashani F; O'Brien S; Manshouri T; Lerner S; Sim S; Dodd K; Kantarjian H; Freireich E; Keating M; Albitar M
    Leuk Res; 2000 Jun; 24(6):469-74. PubMed ID: 10781679
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
    Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
    Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.